Paper10948
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Brittain RT and 1 other. Br J Clin Pharmacol, 1976. Cited by 210 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug. Papers, record 10948. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10948
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic alpha-Antagonists | Major topic |
| Adrenergic beta-Antagonists | Major topic |
| Ethanolamines | Major topic |
| Labetalol | Major topic |
| Animals | |
| Autonomic Fibers, Preganglionic | |
| Desoxycorticosterone | |
| Dogs | |
| Electric Stimulation | |
| Guinea Pigs | |
| Hemodynamics | |
| Hypertension | |
| Hypertension, Renal | |
| In Vitro Techniques | |
| Isoproterenol | |
| Male | |
| Muscle Contraction | |
| Muscle, Smooth | |
| Myocardial Contraction | |
| Phentolamine | |
| Phenylephrine | |
| Propranolol | |
| Rabbits | |
| Rats |
Source PubMed
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 210 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 25,410,787 | BJCP 40th anniversary: moving forward, looking back. | Br J Clin Pharmacol | 2014 | https://conductscience.org/library/papers/25410787 | PubMed |
| 22,994,263 | Sir David Jack: an extraordinary drug discoverer and developer. | Br J Clin Pharmacol | 2013 | https://conductscience.org/library/papers/22994263 | PubMed |
| 17,883,286 | Drugs for the perioperative control of hypertension: current issues and future directions. | Drugs | 2007 | https://conductscience.org/library/papers/17883286 | PubMed |
| 8,934,953 | Induced hypotension during anesthesia with special reference to orthognathic surgery. | Anesth Prog | 1995 | https://conductscience.org/library/papers/8934953 | PubMed |
| 7,388,518 | Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma. | Br Med J | 1980 | https://conductscience.org/library/papers/7388518 | PubMed |
| 7,308,279 | The electrophysiological effects of intravenous labetalol in man. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7308279 | PubMed |
| 7,138,756 | Effect of labetalol, an alpha-and beta-adrenoceptor antagonist, on gastric acid and gastrin secretion in man. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7138756 | PubMed |
| 7,093,092 | Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7093092 | PubMed |
| 7,049,710 | Clinical evaluation of labetalol alone and combined with chlorthalidone in essential hypertension: a double-blind multicentre controlled study. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7049710 | PubMed |
| 7,042,373 | Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7042373 | PubMed |
| 6,992,823 | Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6992823 | PubMed |
| 6,988,003 | Comparison of labetalol and propranolol in hypertension. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6988003 | PubMed |
| 6,914,126 | Ocular hypotensive action of labetalol in rabbit and human eyes. | Albrecht Von Graefes Arch Klin Exp Ophthalmol | 1981 | https://conductscience.org/library/papers/6914126 | PubMed |
| 6,846,084 | Treatment of hypertension with labetalol in neurosurgical practice. Influence of labetalol on cerebral perfusion pressure in dogs without and with intracranial mass lesions. | Acta Neurochir (Wien) | 1983 | https://conductscience.org/library/papers/6846084 | PubMed |
| 6,736,412 | Evaluation of I.V. labetalol for treatment of posttraumatic hyperdynamic state. | Intensive Care Med | 1984 | https://conductscience.org/library/papers/6736412 | PubMed |
| 6,310,204 | Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension. | Klin Wochenschr | 1983 | https://conductscience.org/library/papers/6310204 | PubMed |
| 6,151,889 | Pharmacology of combined alpha-beta-blockade. I. | Drugs | 1984 | https://conductscience.org/library/papers/6151889 | PubMed |
| 6,145,440 | Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6145440 | PubMed |
| 6,127,131 | The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues. | Br J Pharmacol | 1982 | https://conductscience.org/library/papers/6127131 | PubMed |
| 6,125,176 | Effects of beta-adrenoceptor antagonists on central haemodynamics in essential hypertension. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6125176 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10948
GET https://conductscience.org/api/papers/v1/10948/cited_by?page=2